These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2009-013052-76 A single-arm, phase II study of SU11248 (sunitinib) in patients with von Hippel-Lindau (VHL) disease. 2011-03-28 due-trials
Not reported 2011-000882-11 A comparison of blood and tissue biomarkers before and after nephrectomy in the firstline setting with everolimus in patients with locally advanced or metastatic renal cell carcinoma 2015-06-23 due-trials
Ongoing 2014-003774-16 Phase I/II dose-finding, safety and efficacy study of radium-223 dichloride (XOFIGO®) in renal cell carcinoma patients with bone metastases not-yet-due
Ongoing 2016-001179-60 Randomized multicenter, phase III trial evaluating the safety of 2 schedules of cabazitaxel (bi-weekly versus tri-weekly) plus prednisone in elderly men (≥ 65 years) with metastatic castration-resista... not-yet-due